4-Fluoro-5-isopropyl-2-methoxyphenylboronic Acid: A Key Pharmaceutical Intermediate
Essential building block for advanced pharmaceutical synthesis, particularly for Anacetrapib.
Get a Quote & SampleProduct Core Value
4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid
This compound is a critical pharmaceutical intermediate, primarily utilized in the synthesis of Anacetrapib (MK-0859). Anacetrapib is a potent cholesterol ester transfer protein (CETP) inhibitor designed for the treatment of atherosclerosis and dyslipidemia. Its role in stabilizing HDL cholesterol and reducing LDL cholesterol makes intermediates like this highly valuable in drug development.
- Discover the role of this 4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid intermediate in Anacetrapib synthesis.
- Leverage high purity boronic acid intermediates for reliable drug manufacturing.
- Explore the advantages of using specialized MK-0859 intermediate chemicals in your research.
- Learn why sourcing this specific pharmaceutical intermediate is crucial for effective cholesterol management drug development.
Key Advantages
High Purity and Quality
Ensure consistent results in your Anacetrapib synthesis with intermediates offering 98% purity, crucial for pharmaceutical applications.
Strategic Synthesis Component
As a vital 4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid intermediate, it plays a key role in complex organic synthesis pathways for advanced APIs.
Enables Advanced Drug Development
Facilitate the creation of innovative treatments for cardiovascular diseases by utilizing this specialized MK-0859 intermediate chemical.
Key Applications
Anacetrapib Production
This compound is indispensable as a direct 4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid intermediate for the commercial production of Anacetrapib.
Drug Discovery Research
Researchers utilize high purity boronic acid intermediates to explore new therapeutic agents and optimize existing drug synthesis processes.
Cardiovascular Therapies
Its application in developing Anacetrapib directly supports advancements in treating dyslipidemia and atherosclerosis.
Specialty Chemical Synthesis
Beyond Anacetrapib, this chemical can serve as a building block in the synthesis of other complex fluorinated organic molecules.